Ionis repurchases $30.2M of 0.125% convertible notes due 2024 for $29.2M cash

IONIS PHARMACEUTICALS INC

Agreements with certain holders on Aug 21 and Aug 23, 2023; $30.2M principal bought for ~$29.2M cash.
Repurchases were privately negotiated; no impact on note terms for remaining holders.
Company may seek to buy back additional 2024 notes or other debt in open market or private deals.
Retirement of notes reduces outstanding principal and interest obligations.
Future repurchases could be material and affect trading liquidity of the notes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.